Image 15_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 4_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif by Chen Wang (88408)

Image 11_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 5_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif by Chen Wang (88408)

Image 9_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 2_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 13_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 1_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif by Chen Wang (88408)

Image 14_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 12_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

Image 1_L1, a 3,3′-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.tif by Yi Kuang (1873354)

“…Recently, our group synthesized and modified a novel DIM derivative, L1, and demonstrated its significant antileukemic activities.</p>Methods<p>MTT assay was used to confirm the inhibition rates and IC₅₀ value of L1 in erythroleukemia HEL cells. …”

Image 2_L1, a 3,3′-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.tif by Yi Kuang (1873354)

“…Recently, our group synthesized and modified a novel DIM derivative, L1, and demonstrated its significant antileukemic activities.</p>Methods<p>MTT assay was used to confirm the inhibition rates and IC₅₀ value of L1 in erythroleukemia HEL cells. …”

Table 1_Metabolites mediate the effects of healthy lifestyles on the risks of common age-related diseases.xlsx by Yan Li (23143)

“…Furthermore, intermediate or healthy lifestyles significantly decreased the age-related risk of stroke, chronic liver disease, chronic kidney disease (CKD), osteoporosis, osteoarthritis, and hypertension. …”

Data Sheet 1_Combined effect of esaxerenone and dapagliflozin on aldosterone-mediated sodium reabsorption and potassium excretion.docx by Motonobu Nakamura (5944421)

Investigating the Impact of Base Pair Mismatches on Cas13d Cleavage Efficiency Using Molecular Dynamics Simulations by Ye Liu (296340)

“…However, the presence of mismatches significantly undermines the cleavage efficiency of Cas13d to target RNA. …”

Data Sheet 1_Understanding mechanistic relationships between IgG titers and Fc effector functions: a computational framework to assess polyfunctionality.docx by Suzanne K. Shoffner-Beck (22253548)

“…Surprisingly, simulated boosting of IgG3 alone had the potential to significantly decrease ADCP (p<0.00001), though it would increase ADCC responses. …”

Table 1_Has carbon finance been able to promote clean energy development? — a low-carbon technology innovation perspective.xlsx by Rui Cui (622759)

VCC-induced pro-inflammatory responses in DCs are TLR1-dependent but not TLR2-dependent. by Shraddha Gandhi (21001590)

“…(K) Significant decrease in the IL-6 production in the VCC-treated BMDCs from TLR1^-/- mice, as compared to those from the wild type (WT) mice. …”

TLR4 is involved in the VCC-induced activation of BMDCs. by Shraddha Gandhi (21001590)

“…(G-H) Significant decrease in the VCC-mediated IL-6 production in the BMDCs from the C3H/HeJ mice with abrogated TLR4 signalling, compared to that in the BMDCs from the wild type (WT) mice. …”

Image2_DDIT4/mTOR signaling pathway mediates cantharidin-induced hepatotoxicity and cellular damage.tif by Wenchao Tang (14710556)